163 related articles for article (PubMed ID: 21934296)
21. Role of the promyelocytic leukaemia protein in cell death regulation.
Salomoni P; Dvorkina M; Michod D
Cell Death Dis; 2012 Jan; 3(1):e247. PubMed ID: 22237204
[TBL] [Abstract][Full Text] [Related]
22. Fusion proteins of the retinoic acid receptor-alpha recruit histone deacetylase in promyelocytic leukaemia.
Grignani F; De Matteis S; Nervi C; Tomassoni L; Gelmetti V; Cioce M; Fanelli M; Ruthardt M; Ferrara FF; Zamir I; Seiser C; Grignani F; Lazar MA; Minucci S; Pelicci PG
Nature; 1998 Feb; 391(6669):815-8. PubMed ID: 9486655
[TBL] [Abstract][Full Text] [Related]
23. TBLR1 fuses to retinoid acid receptor α in a variant t(3;17)(q26;q21) translocation of acute promyelocytic leukemia.
Chen Y; Li S; Zhou C; Li C; Ru K; Rao Q; Xing H; Tian Z; Tang K; Mi Y; Wang B; Wang M; Wang J
Blood; 2014 Aug; 124(6):936-45. PubMed ID: 24782508
[TBL] [Abstract][Full Text] [Related]
24. Promyelocytic leukemia activates Chk2 by mediating Chk2 autophosphorylation.
Yang S; Jeong JH; Brown AL; Lee CH; Pandolfi PP; Chung JH; Kim MK
J Biol Chem; 2006 Sep; 281(36):26645-54. PubMed ID: 16835227
[TBL] [Abstract][Full Text] [Related]
25. Analysis of t(15;17) chromosomal breakpoint sequences in therapy-related versus de novo acute promyelocytic leukemia: association of DNA breaks with specific DNA motifs at PML and RARA loci.
Hasan SK; Ottone T; Schlenk RF; Xiao Y; Wiemels JL; Mitra ME; Bernasconi P; Di Raimondo F; Stanghellini MT; Marco P; Mays AN; Döhner H; Sanz MA; Amadori S; Grimwade D; Lo-Coco F
Genes Chromosomes Cancer; 2010 Aug; 49(8):726-32. PubMed ID: 20544846
[TBL] [Abstract][Full Text] [Related]
26. Rapid diagnosis of acute promyelocytic leukemia with the PML-RARA fusion gene using a combination of droplet-reverse transcription-polymerase chain reaction and instant-quality fluorescence in situ hybridization.
Shigeto S; Matsuda K; Yamaguchi A; Sueki A; Uehara M; Sugano M; Uehara T; Honda T
Clin Chim Acta; 2016 Jan; 453():38-41. PubMed ID: 26656442
[TBL] [Abstract][Full Text] [Related]
27. Acute promyelocytic leukaemia and the t(15;17) translocation.
Gillard EF; Solomon E
Semin Cancer Biol; 1993 Dec; 4(6):359-67. PubMed ID: 8142621
[TBL] [Abstract][Full Text] [Related]
28. Microarray, gene sequencing, and reverse transcriptase-polymerase chain reaction analyses of a cryptic PML-RARA translocation.
Koshy J; Qian YW; Bhagwath G; Willis M; Kelley TW; Papenhausen P
Cancer Genet; 2012 Oct; 205(10):537-40. PubMed ID: 22982005
[TBL] [Abstract][Full Text] [Related]
29. Acute myeloblastic leukaemias of FAB types M6 and M4, with cryptic PML/RARalpha fusion gene formation, relapsing as acute promyelocytic leukaemia M3.
Virchis A; Massey E; Butler T; Devaraj P; Wright F; Secker-Walker L; Prentice HG; Mehta A
Br J Haematol; 2001 Sep; 114(3):551-6. PubMed ID: 11552979
[TBL] [Abstract][Full Text] [Related]
30. The PML/RARalpha fusion protein inhibits tumor necrosis factor-alpha-induced apoptosis in U937 cells and acute promyelocytic leukemia blasts.
Testa U; Grignani F; Samoggia P; Zanetti C; Riccioni R; Lo Coco F; Diverio D; Felli N; Passerini CG; Grell M; Pelicci PG; Peschle C
J Clin Invest; 1998 May; 101(10):2278-89. PubMed ID: 9593784
[TBL] [Abstract][Full Text] [Related]
31. cAMP signalling is decisive for recovery of nuclear bodies (PODs) during maturation of RA-resistant t(15;17) promyelocytic leukemia NB4 cells expressing PML-RAR alpha.
Duprez E; Lillehaug JR; Naoe T; Lanotte M
Oncogene; 1996 Jun; 12(11):2451-9. PubMed ID: 8649787
[TBL] [Abstract][Full Text] [Related]
32. Differentiation response of acute promyelocytic leukemia cells and PML/RARa leukemogenic activity studies by real-time RT-PCR.
Caprodossi S; Pedinotti M; Amantini C; Santoni G; Minucci S; Pelicci PG; Fanelli M
Mol Biotechnol; 2005 Jul; 30(3):231-8. PubMed ID: 15988048
[TBL] [Abstract][Full Text] [Related]
33. Modified array-based comparative genomic hybridization detects cryptic and variant PML-RARA rearrangements in acute promyelocytic leukemia lacking classic translocations.
Gruver AM; Rogers HJ; Cook JR; Ballif BC; Schultz RA; Batanian JR; Fesler MJ; Tubbs RR
Diagn Mol Pathol; 2013 Mar; 22(1):10-21. PubMed ID: 23370423
[TBL] [Abstract][Full Text] [Related]
34. DNA recognition by the aberrant retinoic acid receptors implicated in human acute promyelocytic leukemia.
Hauksdóttir H; Privalsky ML
Cell Growth Differ; 2001 Feb; 12(2):85-98. PubMed ID: 11243468
[TBL] [Abstract][Full Text] [Related]
35. Distinct interactions of PML-RARalpha and PLZF-RARalpha with co-repressors determine differential responses to RA in APL.
He LZ; Guidez F; Tribioli C; Peruzzi D; Ruthardt M; Zelent A; Pandolfi PP
Nat Genet; 1998 Feb; 18(2):126-35. PubMed ID: 9462740
[TBL] [Abstract][Full Text] [Related]
36. Unexpected heterogeneity of PML/RAR alpha fused mRNA detected by nested polymerase chain reaction in acute promyelocytic leukemia.
Matsuoka A; Miyamura K; Emi N; Tahara T; Tanimoto M; Naoe T; Ohno R; Kakizuka A; Evans RM; Saito H
Leukemia; 1993 Aug; 7(8):1151-5. PubMed ID: 8394480
[TBL] [Abstract][Full Text] [Related]
37. Acute promyelocytic leukemia with insertion of PML exon 7a and partial deletion of exon 3 of RARA: a novel variant transcript related to aggressive course and not detected with real-time polymerase chain reaction analysis.
Park TS; Kim JS; Song J; Lee KA; Yoon S; Suh B; Lee JH; Lee HJ; Kim JK; Choi JR
Cancer Genet Cytogenet; 2009 Jan; 188(2):103-7. PubMed ID: 19100514
[TBL] [Abstract][Full Text] [Related]
38. Reverse transcription-polymerase chain reaction for PML-RAR alpha fusion transcripts in acute promyelocytic leukemia and its application to minimal residual leukemia detection.
Ikeda K; Sasaki K; Tasaka T; Nagai M; Kawanishi K; Takahara J; Irino S
Leukemia; 1993 Apr; 7(4):544-8. PubMed ID: 8385249
[TBL] [Abstract][Full Text] [Related]
39. Acute promyelocytic leukemia with a STAT5b-RARα fusion transcript defined by array-CGH, FISH, and RT-PCR.
Chen H; Pan J; Yao L; Wu L; Zhu J; Wang W; Liu C; Han Q; Du G; Cen J; Xue Y; Wu D; Sun M; Chen S
Cancer Genet; 2012 Jun; 205(6):327-31. PubMed ID: 22749039
[TBL] [Abstract][Full Text] [Related]
40. Use of whole-genome sequencing to diagnose a cryptic fusion oncogene.
Welch JS; Westervelt P; Ding L; Larson DE; Klco JM; Kulkarni S; Wallis J; Chen K; Payton JE; Fulton RS; Veizer J; Schmidt H; Vickery TL; Heath S; Watson MA; Tomasson MH; Link DC; Graubert TA; DiPersio JF; Mardis ER; Ley TJ; Wilson RK
JAMA; 2011 Apr; 305(15):1577-84. PubMed ID: 21505136
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
